enVVeno Medical Corporati...

NASDAQ: NVNO · Real-Time Price · USD
4.64
0.14 (3.11%)
At close: Aug 15, 2025, 2:20 PM

enVVeno Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-25.19M -21.33M -21.82M -21.24M -20.6M -22.12M -23.52M -24.05M -25.14M -25.73M -24.67M -27.48M -23.77M -19.08M -16.53M -11.91M -11.5M -10.75M
Depreciation & Amortization
517.5K 509K 528K 540K 549K 551K 546K 542K 537K 532K 525K 516.59K 503.73K 478.23K 452.91K 427.3K 405.7K 401.59K
Stock-Based Compensation
4.56M 3.67M 4.14M 4.26M 4.37M 4.52M 5.2M 6.29M 7.46M 8.54M 8.99M 12.1M 10.15M 8.11M 6M 1.17M 1.04M 879.49K
Other Working Capital
-752K -999K -879K -451K -248K -175K -395K -334K -169K 157K -56K 213.93K 190.25K -83.17K -312.1K 127.35K -186.55K -71.82K
Other Non-Cash Items
1.23M 1.19M 2.72M -2.73M -4.94M 1.05M -468K 4.32M 6.29M -670K -440K -260.96K -99.51K -281.06K -312.61K -307.82K -301.44K -300.93K
Deferred Income Tax
n/a n/a n/a 5.14M 7.2M n/a n/a -5.14M -7.2M n/a n/a n/a -312.7K -312.7K -312.7K -284.9K 80.85K 162.12K
Change in Working Capital
418.75K -230K n/a -277K -814K -18K -616K 297K -61K -182K -130K 158.82K 915.45K -237.75K -1.14M -455.11K -1.45M -760.39K
Operating Cash Flow
-18.46M -17.31M -16.84M -16.71M -16.64M -17.3M -18.86M -17.74M -18.01M -17.41M -15.62M -14.86M -12.61M -11.33M -11.85M -11.36M -11.72M -10.37M
Capital Expenditures
108.48K -27K -37K -37K -31K -38K -33K -38K -49K -51K -115K -170.75K -309.38K -412.86K -367.89K -330.68K -203.01K -199K
Cash Acquisitions
n/a n/a n/a 14.3K 9.86K 2.83K n/a -19.83K -15.38K -8.36K -5.53K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-56.18M -49.31M -55.57M -65.66M -66.49M -63.03M -56.52M -30.19M -24.94M -56.76M -48.13M -42.21M -38.29M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
64.59M 53.67M 56.94M 55.95M 54.99M 54.57M 48.69M 50.02M 36.39M 22.9M 11.44M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 3.99M 6.2M 6.18M 6.19M 2.2M n/a 19.83K -1.66M -1.71M -1.71M -1.72M -38.29K n/a n/a n/a n/a n/a
Investing Cash Flow
8.51M 4.34M 1.33M -9.75M -11.53M -8.5M -7.87M 19.79M 13.65M -31.66M -34.55M -40.13M -38.6M -412.86K -367.89K -330.68K -203.01K -199K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
13.59M 13.59M 13.64M 39.43M 25.84M 25.84M 25.79M n/a n/a n/a n/a -50 18.27M 18.27M 18.51M 21.66M 4.8M 7.09M
Financial Cash Flow
13.59M 13.59M 13.64M 39.43M 25.84M 25.84M 25.79M n/a n/a n/a n/a -5.05K 19.24M 19.24M 57.61M 63.96M 50.59M 52.87M
Net Cash Flow
-38.44M 623K -1.87M 12.97M -2.33M 41K -935K 2.05M -4.36M -49.06M -50.17M -55M -31.97M 7.5M 45.39M 52.27M 38.67M 42.31M
Free Cash Flow
-18.35M -17.33M -16.88M -16.74M -16.67M -17.34M -18.89M -17.78M -18.06M -17.46M -15.73M -15.03M -12.92M -11.74M -12.21M -11.69M -11.92M -10.57M